{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:26Z","timestamp":1786118966237,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/jcp.0b013e31818455fc","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T07:01:02Z","timestamp":1221202862000},"page":"518-524","source":"Crossref","is-referenced-by-count":27,"title":["The Alpha 2A-Adrenergic Receptor Gene Polymorphism Modifies Antidepressant Responses to Milnacipran"],"prefix":"10.1097","volume":"28","author":[{"given":"Masataka","family":"Wakeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Takekita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Nonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000094727","article-title":"Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.","volume":"53","author":"Kato","year":"2006","journal-title":"Neuropsychobiology"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0893-133X(00)00132-9","article-title":"Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.","volume":"23","author":"Pollock","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mp.4000425","article-title":"Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.","volume":"3","author":"Smeraldi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001756-200001170-00042","article-title":"Serotonin transporter gene polymorphism and antidepressant response.","volume":"11","author":"Kim","year":"2000","journal-title":"Neuroreport"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1176\/appi.ajp.161.9.1575","article-title":"Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.","volume":"161","author":"Yoshida","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.296.13.1609","article-title":"Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression.","volume":"296","author":"Kim","year":"2006","journal-title":"JAMA"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0006-3223(99)00127-4","article-title":"Role of norepinephrine in the pathophysiology and treatment of mood disorders.","volume":"46","author":"Ressler","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S1461145704004687","article-title":"The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.","volume":"7","author":"Serretti","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.euroneuro.2005.12.004","article-title":"Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders.","volume":"16","author":"Yu","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1210\/me.2003-0035","article-title":"Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.","volume":"17","author":"Brede","year":"2003","journal-title":"Mol Endocrinol"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1152\/ajpregu.00123.2002","article-title":"Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.","volume":"283","author":"Philipp","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0006-3223(00)01050-7","article-title":"Noradrenergic dysfunction in the prefrontal cortex in depression: an 150 H2O PET study of the neuromodulatory effects of clonidine.","volume":"49","author":"Fu","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1471-4159.1999.0720282.x","article-title":"Up-regulation of immunolabeled 2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides.","volume":"72","author":"Garcia-Sevilla","year":"1999","journal-title":"J Neurochem"},{"key":"R14-7-20210128","first-page":"755","article-title":"Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors.","volume":"7","author":"Gonzalez-Maeso","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1460-9568.2003.02510.x","article-title":"2A and 2C-adrenoceptor regulation in the brain: 2A changes persist after chronic stress.","volume":"17","author":"Flugge","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archpsyc.1981.01780370029003","article-title":"Platelet 2-adrenergic receptors in major depressive disorder: binding of tritiated clonidine before and after tricyclic antidepressant drug treatment.","volume":"38","author":"Garcia-Sevilla","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1990.01810140025005","article-title":"2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression.","volume":"47","author":"Garcia-Sevilla","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-1781(99)00103-1","article-title":"Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome.","volume":"89","author":"Gurguis","year":"1999","journal-title":"Psychiatry Res"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(97)00138-8","article-title":"Brain alpha-adrenoceptors in depressed suicides.","volume":"757","author":"De Paermentier","year":"1997","journal-title":"Brain Res"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/sj.npp.1300459","article-title":"Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims.","volume":"29","author":"Escriba","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0006-3223(92)90259-3","article-title":"Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression.","volume":"31","author":"Meana","year":"1992","journal-title":"Biol Psychiatry"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety.","volume":"21","author":"Schramm","year":"2001","journal-title":"J Neurosci"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.mp.4001743","article-title":"Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit\/hyperactivity disorder.","volume":"11","author":"Roman","year":"2006","journal-title":"Mol Psychiatry"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.biopsych.2006.02.035","article-title":"Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type.","volume":"60","author":"Schmitz","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3758\/CABN.6.1.18","article-title":"The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD.","volume":"6","author":"Waldman","year":"2006","journal-title":"Cogn Affect Behav Neurosci"},{"key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.b.10056","article-title":"A \"line item\" approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic alpha2A (ADRA2A) gene.","volume":"118","author":"Comings","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajmg.b.30311","article-title":"Weight gain associated with the alpha2a-adrenergic receptor -1,291 C\/G polymorphism and olanzapine treatment.","volume":"141","author":"Park","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00702-005-0291-7","article-title":"Polymorphism of the adrenergic receptor alpha 2a -1291CG genetic variation and clozapine-induced weight gain.","volume":"112","author":"Wang","year":"2005","journal-title":"J Neural Transm"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1016\/S0021-9258(18)80130-2","article-title":"Cloning, sequence analysis, and permanent expression of a human alpha 2-adrenergic receptor in Chinese hamster ovary cells.","volume":"264","author":"Fraser","year":"1989","journal-title":"J Biol Chem"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1399-0004.1997.tb02436.x","article-title":"MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene.","volume":"51","author":"Lario","year":"1997","journal-title":"Clin Genet"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.jcp.0000104904.75206.19","article-title":"Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment.","volume":"24","author":"Shinkai","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2004.07.002","article-title":"A comparative study of milnacipran and paroxetine in outpatients with major depression.","volume":"83","author":"Sechter","year":"2004","journal-title":"J Affect Disord"},{"key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1176\/appi.ajp.159.10.1702","article-title":"Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine.","volume":"159","author":"Gilmor","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00001756-199805110-00006","article-title":"Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders.","volume":"9","author":"Ohara","year":"1998","journal-title":"Neuroreport"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.psychres.2003.12.002","article-title":"Alpha 2A adrenergic receptor gene and suicide.","volume":"125","author":"Sequeira","year":"2004","journal-title":"Psychiatry Res"},{"key":"R39-7-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archpsyc.64.2.218","article-title":"Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit\/hyperactivity disorder.","volume":"64","author":"Polanczyk","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"6968","key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The international HapMap project.","volume":"426","year":"2003","journal-title":"Nature"},{"issue":"6","key":"R41-7-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00406-005-0579-5","article-title":"Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.","volume":"255","author":"Adli","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e31818455fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:10:49Z","timestamp":1786036249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200810000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31818455fc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}